(CRIT) Optica Rare Earths - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3015055250 • Equity Precious Metals
CRIT: Rare Earth Elements, Tantalum, Cobalt, Lithium, Manganese, Nickel, Copper
The Optica Rare Earths & Critical Materials ETF (NYSE ARCA: CRIT) is designed to provide exposure to companies involved in the rare earths and critical materials sector, which are essential for advanced technologies, renewable energy systems, and strategic industries. The fund tracks an index that includes companies deriving at least 50% of their revenue from rare earths and critical materials, or those with projects expected to meet this threshold once operational. This focus allows investors to tap into the growing demand for materials like neodymium, dysprosium, lithium, and cobalt, which are crucial for electric vehicle batteries, wind turbines, and high-tech electronics.
As a non-diversified fund, CRIT can invest a larger portion of its assets in a smaller number of holdings, which may amplify risks but also increases potential returns. The fund is listed on the NYSE ARCA under the ticker CRIT and falls under the Equity Precious Metals ETF category. Its average trading volume over the past 20 days has been 2,000 shares, indicating moderate liquidity. The funds assets under management (AUM) stand at $3.09 million, reflecting its niche focus. From a technical perspective, CRIT is trading at $15.95, slightly below its 20-day simple moving average (SMA) of $16.15 but closer to its 50-day SMA of $16.29. The 200-day SMA of $17.45 suggests the fund has been in a downtrend over the past year. The average true range (ATR) of 0.32 indicates moderate volatility.
Over the next three months, CRIT is expected to face headwinds due to its low trading volume, which could lead to higher volatility. The funds price may remain under pressure as it is currently trading below its key moving averages. However, any positive developments in the rare earths and critical materials sector, such as increased demand for green energy technologies or supply chain improvements, could provide upside potential. Investors should monitor the funds performance relative to its moving averages and overall market conditions in the rare earths sector.
Additional Sources for CRIT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRIT ETF Overview
Market Cap in USD | 3m |
Category | Equity Precious Metals |
TER | 0.85% |
IPO / Inception | 2022-03-28 |
CRIT ETF Ratings
Growth 5y | -53.1% |
Fundamental | - |
Dividend | 47.7% |
Rel. Strength | -10.2 |
Analysts | - |
Fair Price Momentum | 13.96 USD |
Fair Price DCF | - |
CRIT Dividends
Dividend Yield 12m | 1.86% |
Yield on Cost 5y | 1.34% |
Annual Growth 5y | 20.19% |
Payout Consistency | 89.7% |
CRIT Growth Ratios
Growth Correlation 3m | -16.2% |
Growth Correlation 12m | -67% |
Growth Correlation 5y | -55.5% |
CAGR 5y | -12.13% |
CAGR/Max DD 5y | -0.32 |
Sharpe Ratio 12m | -0.28 |
Alpha | -8.89 |
Beta | 1.134 |
Volatility | 26.02% |
Current Volume | 0k |
Average Volume 20d | 1.2k |
As of April 06, 2025, the stock is trading at USD 16.08 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +4.57%, over three months by -1.87% and over the past year by -15.32%.
No, based on ValueRay Analyses, Optica Rare Earths (NYSE ARCA:CRIT) is currently (April 2025) a stock to sell. It has a ValueRay Growth Rating of -53.08 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRIT as of April 2025 is 13.96. This means that CRIT is currently overvalued and has a potential downside of -13.18%.
Optica Rare Earths has no consensus analysts rating.
According to ValueRays Forecast Model, CRIT Optica Rare Earths will be worth about 15.6 in April 2026. The stock is currently trading at 16.08. This means that the stock has a potential downside of -2.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 15.6 | -3% |